Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmaceutical Poisoning: Treatment Strategies01:26

Pharmaceutical Poisoning: Treatment Strategies

Treatment strategies for poisoning are a critical aspect of emergency medicine, focusing on preventing the absorption of toxins and enhancing their elimination. When a poisoning incident occurs, the first response is to halt exposure and decontaminate the patient, particularly through gastrointestinal (GI) methods if the poison was ingested.Gastrointestinal Decontamination Techniques:Activated charcoal is the cornerstone of GI decontamination. It works through adsorption, binding the toxin to...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Hepatic Encephalopathy01:29

Hepatic Encephalopathy

DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...
Anticholinesterase Agents: Poisoning and Treatment01:26

Anticholinesterase Agents: Poisoning and Treatment

Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.     
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Neurotoxicity of antimony: A review of epidemiological evidence and the underlying molecular mechanisms.

Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements (GMS)·2026
Same author

Molecular Mechanisms of Manganese Oxide Nanoparticles Toxicity in Brain and Other Tissues: An Overview.

Frontiers in bioscience (Landmark edition)·2026
Same author

The protective effects of selenium on mitochondrial quality under exogenous and endogenous stressors.

Chemico-biological interactions·2026
Same author

Neurotoxicity of copper and copper oxide nanoparticles.

Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association·2026
Same author

The effects of nanoplastics on toxicity of metals and metal nanoparticles: molecular mechanisms and health effects.

Archives of toxicology·2026
Same author

Kynurenine Pathway, Nrf2 and NF-κB Cross-Regulation in the CNS: An Overview.

Molecular neurobiology·2026

Related Experiment Video

Updated: May 9, 2026

Experimental Models to Study the Neuroprotection of Acidic Postconditioning Against Cerebral Ischemia
10:13

Experimental Models to Study the Neuroprotection of Acidic Postconditioning Against Cerebral Ischemia

Published on: July 31, 2017

Probenecid: an emerging tool for neuroprotection.

Ana Laura Colín-González1, Abel Santamaría

  • 1Laboratorio de Aminoácidos Excitadores, Instituto Nacional de Neurología y Neurocirugía, Insurgentes Sur 3877, México D.F. 14269, México. absada@yahoo.com.

CNS & Neurological Disorders Drug Targets
|July 13, 2013
PubMed
Summary

Probenecid (PROB) is a versatile drug used in gout and as an antibiotic adjunct. Its CNS effects, particularly preserving metabolites and inhibiting excitotoxicity, highlight its value in neurological research and potential anti-inflammatory roles.

Related Experiment Videos

Last Updated: May 9, 2026

Experimental Models to Study the Neuroprotection of Acidic Postconditioning Against Cerebral Ischemia
10:13

Experimental Models to Study the Neuroprotection of Acidic Postconditioning Against Cerebral Ischemia

Published on: July 31, 2017

Area of Science:

  • Pharmacology
  • Neuroscience
  • Drug Discovery

Background:

  • Probenecid (PROB) is a long-established medication with diverse clinical applications, including gout treatment and as a coadjutant for antibiotics.
  • Its ability to maintain elevated concentrations of various agents within the central nervous system (CNS) and its favorable side-effect profile make it a valuable tool in both clinical and basic research.
  • Emerging research suggests novel targets for PROB, potentially explaining its wide-ranging beneficial effects.

Purpose of the Study:

  • To review the fundamental pharmacokinetics and mechanisms of action of Probenecid (PROB).
  • To discuss recently identified alternative targets for PROB within the CNS.
  • To explore PROB's emerging roles as an anti-inflammatory and anti-nociceptive agent through interactions with specific key proteins.

Main Methods:

  • Literature review of existing studies on Probenecid (PROB).
  • Analysis of pharmacokinetic data and established mechanisms of action.
  • Examination of recent research on novel molecular targets and therapeutic applications.

Main Results:

  • Probenecid (PROB) is known to accumulate the metabolite kynurenic acid, which inhibits glutamate-related excitotoxicity, offering neuroprotection in various neurological disorder models.
  • The review details PROB's pharmacokinetic properties and primary mechanisms of action.
  • Alternative targets and potential anti-inflammatory and anti-nociceptive activities of PROB are discussed, expanding its known therapeutic profile.

Conclusions:

  • Probenecid (PROB) possesses significant neuroprotective capabilities, primarily through modulating kynurenic acid levels and inhibiting excitotoxicity.
  • Beyond its established roles, PROB exhibits potential as an anti-inflammatory and anti-nociceptive agent by interacting with novel protein targets.
  • This review underscores the multifaceted therapeutic potential of Probenecid (PROB) in the CNS, warranting further investigation into its expanded applications.